BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3918965)

  • 1. Radiotherapeutic management of primary thyroid lymphoma.
    Blair TJ; Evans RG; Buskirk SJ; Banks PM; Earle JD
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):365-70. PubMed ID: 3918965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid lymphoma. The case for combined modality therapy.
    Doria R; Jekel JF; Cooper DL
    Cancer; 1994 Jan; 73(1):200-6. PubMed ID: 8275426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
    Hoederath A; Sack H; Stuschke M; Lampka E
    Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adjuvant radiotherapy and chemoradiotherapy following surgery in stage IE and IIE primary gastrointestinal tract non-Hodgkin's lymphoma.
    Chung HC; Roh JK; Koh EH; Kim JH; Hahn JS; Park IS; Min JS; Lee KS; Suh CO; Loh JJ
    Yonsei Med J; 1990 Jun; 31(2):144-55. PubMed ID: 2219972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
    Li YX; Coucke PA; Li JY; Gu DZ; Liu XF; Zhou LQ; Mirimanoff RO; Yu ZH; Huang YR
    Cancer; 1998 Aug; 83(3):449-56. PubMed ID: 9690537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative radiotherapy for primary orbital lymphoma.
    Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of radiotherapy in the treatment of non-Hodgkin's lymphoma of the thyroid].
    Ikeda H; Masaki N; Nishiyama K; Aozasa K
    Gan No Rinsho; 1986 Mar; 32(3):225-33. PubMed ID: 3086595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary lymphoma of the thyroid: clinical features, prognostic factors, and results of treatment.
    Tupchong L; Hughes F; Harmer CL
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1813-21. PubMed ID: 3759532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radiation therapy in localized resectable intestinal non-Hodgkin's lymphoma in children.
    Nelson DF; Cassady JR; Traggis D; Baez-Giangreco A; Vawter GF; Jaffe N; Filler RM
    Cancer; 1977 Jan; 39(1):89-97. PubMed ID: 401677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic fracture after radiation therapy for primary non-Hodgkin's malignant lymphoma of bone.
    Stokes SH; Walz BJ
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1153-9. PubMed ID: 6347996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience.
    Harrington KJ; Michalaki VJ; Vini L; Nutting CM; Syrigos KN; A'hern R; Harmer CL
    Br J Radiol; 2005 May; 78(929):405-10. PubMed ID: 15845932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
    Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
    Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment.
    Vigliotti A; Kong JS; Fuller LM; Velasquez WS
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1807-12. PubMed ID: 2428787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck.
    Mill WB; Lee FA; Franssila KO
    Cancer; 1980 Feb; 45(4):653-61. PubMed ID: 6766790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre.
    Alzouebi M; Goepel JR; Horsman JM; Hancock BW
    Int J Oncol; 2012 Jun; 40(6):2075-80. PubMed ID: 22367111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.